Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 123.15% | -69.55% | 16.34% | 161.33% | -61.92% |
Total Depreciation and Amortization | 11.34% | -11.60% | 46.71% | -33.76% | 13.02% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -91.10% | 212.00% | -17.38% | -229.97% | 1,294.46% |
Change in Net Operating Assets | -274.99% | -60.58% | 380.46% | 126.76% | -447.14% |
Cash from Operations | -80.67% | -18.11% | 127.34% | 244.56% | -82.15% |
Capital Expenditure | 40.21% | -41.14% | -5.94% | -18.04% | 46.05% |
Sale of Property, Plant, and Equipment | -54.98% | 274.93% | -168.18% | 41.99% | -61.06% |
Cash Acquisitions | -133.56% | 239.53% | -95.31% | -840.52% | -94.99% |
Divestitures | -85.38% | 11,289.08% | -99.76% | 1,052.44% | -72.71% |
Other Investing Activities | 165.70% | 19.58% | -288.09% | 1.45% | 193.29% |
Cash from Investing | 10.35% | 47.45% | -169.64% | 567.78% | 28.56% |
Total Debt Issued | 239.16% | -1,538.16% | 106.65% | -126.84% | 382.03% |
Total Debt Repaid | 75.68% | -92.98% | -2.94% | 28.33% | 6.92% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | 100.00% | -- | -- |
Other Financing Activities | 53.03% | -45.06% | -250.01% | 51.62% | 21.03% |
Cash from Financing | 85.80% | -96.16% | 41.81% | -186.63% | 60.83% |
Foreign Exchange rate Adjustments | -143.60% | 498.43% | -63.54% | -69.57% | 81.07% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 47.85% | -171.10% | 451.02% | 66.23% | -61.21% |